Stockreport

BioAge Labs, Inc. (BIOA) Discusses Phase I Results and Development Plans for BGE-102 NLRP3 Inhibitor Transcript [Seeking Alpha]

BioAge Labs, Inc.  (BIOA) 
Last bioage labs, inc. earnings: 8/3 07:00 am Check Earnings Report
US:NYSE Investor Relations: investor.bio-amber.com
PDF Chris Patil Kristen Fortney - Co-Founder, CEO, President, Treasurer, Secretary & Director Paul Rubin - Chief Medical Officer & Executive VP of Research Conference [Read more]